VeriMomIst bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer in der Schwangerschaft sicher?
No harmonised CLP reproductive classification listed in ECHA Annex VI and no SCCS or CIR safety assessment identifying reproductive hazard for this polymer. Peer‑reviewed or regulatory literature does not report teratogenicity or reproductive toxicity for the polymer itself; concerns would be about residual monomers such as HEMA or isocyanates, but no data show reproductive effects from the finished polymer as used in cosmetics (sources consulted: ECHA Annex VI, SCCS/CIR absence, PubMed absence).
Related ingredients
Frequently asked questions
- Ist bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification listed in ECHA Annex VI and no SCCS or CIR safety assessment identifying reproductive hazard for this polymer. Peer‑reviewed or regulatory literature does not report teratogenicity or reproductive toxicity for the polymer itself; concerns would be about residual monomers such as HEMA or isocyanates, but no data show reproductive effects from the finished polymer as used in cosmetics (sources consulted: ECHA Annex VI, SCCS/CIR absence, PubMed absence).
- Ist bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer während des Stillens sicher?
- As for pregnancy: the polymer has high molecular weight and is expected to have negligible systemic absorption when applied topically; no evidence of transfer via breastmilk for the polymer itself reported in regulatory or peer‑reviewed sources. Potential issue would be unreacted monomers, but no regulatory assessments identify breastfeeding risk for the finished polymer (sources: CIR/SCCS absence, PubMed absence, CosIng/ECHA listings if present without classification).
- Ist bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer sicher für Babyhaut?
- High molecular weight polymeric material is expected to have negligible dermal absorption in adults and in infants; no data indicate infant‑specific reproductive mechanism or developmental toxicity from the polymer. Because the polymer is large and crosslinked, dermal penetration is unlikely; therefore exposure for 0–3 y is considered negligible. Note: if residual low‑MW monomers/oligomers (HEMA, IPDI fragments) are present at meaningful levels, infant exposure could be higher—no data on residual monomer content were found (sources: ECHA, CosIng, PubMed).
- Wie bewertet VeriMom bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer?
- VeriMom bewertet bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.